The IVD market will continue to develop rapidly in the next 5 years.

The 6th National Congress of China Medical Equipment Association and the 24th Annual Academic Meeting were held in Xiamen, Fujian Province. The "China Medical Equipment Green Paper - 2014 China Medical Equipment Allocation Status and Development Trends" (hereinafter referred to as "Green Paper") released at the meeting mentioned that in 2013, the total size of China's in vitro diagnostic (IVD) market was 288. About 100 million yuan, the average annual growth rate of the market in 2008-2013 is 23.6%. It is estimated that the scale of China's IVD market will reach 57.2 billion yuan in 2020.

Policy promotes the development of IVD industry

"The continuous improvement of China's medical system, the country's relevant policies from strengthening treatment support to strengthening prevention and detection, the implementation of major disease screening programs, and a number of support policies for the development of IVD industry will continue to drive the expansion of the IVD market. Zhao Zilin, executive vice president of the China Medical Equipment Association, pointed out.

According to analysis, the direct driving effect of the policy on the IVD industry comes from the importance of prevention and detection of major diseases, such as the "Management Program for Rural Women's "Two Cancers" Inspection Project" and "Administrative Measures for Early Diagnosis and Treatment of Urban Cancer (Trial)" The cancer screening work of rural women and urban populations puts forward the implementation requirements and funding guarantees. The "China Chronic Disease Prevention and Control Work Plan (2012-2015)" requires the promotion of appropriate technologies for disease screening and health checkups, and the prevention and treatment of advances; It is from the IVD listed in the relevant industry development plan, "Notice on the organization of the implementation of high-tech industrialization of biological vaccines and diagnostic reagents", "National Medium- and Long-term Scientific and Technological Development Plan (2006 ~ 2020)", "Promotion "Several policies for accelerating the development of the biological industry", "National "Twelfth Five-Year" Science and Technology Development Plan", "Twelfth Five-Year Plan for Biotechnology Development", "Special Plan for the Twelfth Five-Year Plan for Medical Device Technology Industry", The Bio-Industry Development Plan, etc., all have strategic layout, optimization and upgrading, major special projects and technologies for the IVD industry. Innovation and other design plans were carried out.

Biochemical diagnostic needs continue to grow

The "Green Book" mentioned that the IVD market mainly includes three parts: diagnostic reagents, consumables and instruments. Among them, diagnostic reagents account for the largest proportion, about 70%, and the remaining 30% are diagnostic equipment and consumables markets. In the IVD reagent market, immunodiagnostic reagents and biochemical diagnostic reagents are mainstream products. In 2013, the market size of IVD reagents in China was about 20.2 billion yuan, of which the proportion of immunodiagnostic reagents and biochemical diagnostic reagents was 35% and 32%, respectively, and the total proportion of other diagnostic reagents such as molecular diagnostic reagents was 33%. It is expected that the average annual growth rate of China's biochemical diagnostic reagent market will be around 14%. In 2020, the market size will reach 16.2 billion yuan.

According to experts from the China Medical Equipment Association, biochemical diagnosis is the most routine test in China's hospitals. With the continuous release of medical needs, the number of hospital visits and the increase in medical examination requirements, biochemical diagnosis business will inevitably grow rapidly. At the same time, with the decline of the new medical reform in the construction of infrastructure equipment at the grassroots level, the pattern of market distribution as a growth engine has gradually failed, and the change of the drug zero rate policy and the performance appraisal methods of hospitals will promote the hospital. Increase the emphasis on diagnostics.

Portable Air Hose Reel

Small Air Hose Reel,Portable Air Hose Reel,Wall Mount Air Hose Reel,Commercial Air Hose Reel

NINGBO QIKAI ENVIRONMENTAL TECHNOLOGY CO.,LTD , https://www.water-hose-reel.com

Posted on